Table 5.
Comparison of demographic variables between the patients with and without thrombus development in the major systemic and portal vein after BRTO.
| Thrombus | Yes (n = 7) | No (n = 70) | P value |
|---|---|---|---|
| Age (years) | 57.4 ± 12.3 | 61.9 ± 12.2 | 0.3480 |
| Gender | 0.7937 | ||
| Male | 5 | 46 | |
| Female | 2 | 24 | |
| Timing of treatment | 0.7175 | ||
| Emergency cases | 1 | 14 | |
| Prophylactic cases | 6 | 56 | |
| Etiology | 0.6666 | ||
| Viral infection | 3 | 36 | |
| No viral infection | 4 | 34 | |
| Serum albumin (g/dL) | 2.8 ± 0.49 | 3.27 ± 0.59 | 0.0566 |
| Serum total bilirubin (mg/dL) |
1.34 ± 0.59 | 1.25 ± 0.73 | 0.7470 |
| Prothrombin time (%) | 65.57 ± 13.55 | 73.44 ± 13.06 | 0.1370 |
| Platelets (×104 μL) | 9.48 ± 2.43 | 9.12 ± 3.85 | 0.8062 |
| Child-Pugh score | 8.28 ± 1.70 | 7.10 ± 1.66 | 0.0873 |
| Hepatocellular carcinoma | 0.9704 | ||
| Present | 3 | 27 | |
| Absent | 4 | 43 | |
| CT findings | |||
| Ascites | 2 | 24 | 0.7611 |
| Pleural effusion | 4 | 27 | 0.3479 |